The Potential Role of Renal Denervation in the Management of Heart Failure.

heart failure renal denervation therapies

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
17 Jul 2022
Historique:
received: 16 06 2022
revised: 14 07 2022
accepted: 15 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Sympathetic nervous system activation in patients with heart failure is one of the main pathophysiologic mechanisms associated with the worse outcomes. Pharmacotherapies targeting neurohormonal activation have been at the center of heart failure management. Despite the advancement of therapies and the available treatments, heart failure continues to have an overall poor prognosis. Renal denervation was originally developed to lower systemic blood pressure in patients with poorly controlled hypertension, by modulating sympathetic outflow. However, more recently, multiple studies have investigated the effect of renal denervation in heart failure patients with both preserved (HFpEF) and reduced ejection fractions (HFrEF). This paper provides an overview of the potential effect of renal denervation in altering the various pathophysiologic, sympathetically mediated pathways that contribute to heart failure, and reviews the literature that supports its future use in those patients.

Identifiants

pubmed: 35887912
pii: jcm11144147
doi: 10.3390/jcm11144147
pmc: PMC9324976
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Appl Physiol (1985). 2010 Feb;108(2):227-37
pubmed: 19940096
Hypertension. 2005 Nov;46(5):1213-8
pubmed: 16216989
Eur Heart J. 2005 May;26(9):906-13
pubmed: 15764611
JAMA Intern Med. 2013 Mar 25;173(6):468-70
pubmed: 23400219
Eur Heart J. 2014 Sep 1;35(33):2224-31b
pubmed: 24603307
Annu Rev Physiol. 2021 Feb 10;83:39-58
pubmed: 33074771
Trends Cardiovasc Med. 2014 Jul;24(5):206-13
pubmed: 25017919
Eur Heart J. 1988 Aug;9(8):844-52
pubmed: 2460351
Rev Port Cardiol. 2017 Jan;36(1):45-51
pubmed: 27988231
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Integr Blood Press Control. 2015 Dec 03;8:57-69
pubmed: 26672761
J Am Coll Cardiol. 2022 May 3;79(17):1757-1780
pubmed: 35379504
JAMA Cardiol. 2019 Nov 1;4(11):1102-1111
pubmed: 31479100
JACC Clin Electrophysiol. 2021 Jan;7(1):100-108
pubmed: 33478701
Heart Rhythm. 2013 Oct;10(10):1525-30
pubmed: 23851058
EuroIntervention. 2014 Jul;10(3):392-9
pubmed: 25042267
Lancet. 2018 Jun 9;391(10137):2335-2345
pubmed: 29803590
J Am Coll Cardiol. 2012 Mar 6;59(10):901-9
pubmed: 22381425
N Engl J Med. 2014 Apr 10;370(15):1383-92
pubmed: 24716680
Hypertension. 2020 Jan;75(1):23-32
pubmed: 31786973
J Am Heart Assoc. 2018 Oct 16;7(20):e009938
pubmed: 30371294
Cardiol J. 2019;26(5):503-510
pubmed: 29611171
Cardiovasc Diabetol. 2021 Jun 5;20(1):117
pubmed: 34090434
Circulation. 1992 Feb;85(2):790-804
pubmed: 1370925
JAMA. 2020 Jan 21;323(3):248-255
pubmed: 31961420
Arch Intern Med. 1999 Feb 8;159(3):225-34
pubmed: 9989534
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
Heliyon. 2022 Jan 31;8(1):e08847
pubmed: 35141435
J Am Coll Cardiol. 2017 Oct 24;70(17):2139-2153
pubmed: 29050562
Circulation. 1990 Nov;82(5):1724-9
pubmed: 2146040
J Card Fail. 2017 Sep;23(9):702-707
pubmed: 28645757
Eur Heart J. 2011 Mar;32(6):670-9
pubmed: 21138935
J Am Coll Cardiol. 2012 Sep 25;60(13):1163-70
pubmed: 22958958
Circ Heart Fail. 2021 Mar;14(3):e007421
pubmed: 33706547
Lancet. 2018 Jun 9;391(10137):2346-2355
pubmed: 29803589
Int J Cardiol. 2013 Jan 20;162(3):189-92
pubmed: 23031283
Curr Hypertens Rep. 2018 May 1;20(5):37
pubmed: 29717380
Lancet. 2020 Sep 19;396(10254):819-829
pubmed: 32877652
Nat Rev Cardiol. 2017 Jan;14(1):30-38
pubmed: 27708278
J Am Coll Cardiol. 2018 Nov 27;72(21):2609-2621
pubmed: 30466519
Postepy Kardiol Interwencyjnej. 2019;15(2):240-246
pubmed: 31497058
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H337-46
pubmed: 27288440
J Hum Hypertens. 2022 Jan 29;:
pubmed: 35094013
BMC Cardiovasc Disord. 2018 May 8;18(1):86
pubmed: 29739333
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
N Engl J Med. 1992 Dec 31;327(27):1912-8
pubmed: 1454086
Circ Heart Fail. 2021 Mar;14(3):e008301
pubmed: 33706548
Circ Res. 2016 Jul 22;119(3):470-80
pubmed: 27296507
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Int J Clin Exp Med. 2015 Jun 15;8(6):9779-85
pubmed: 26309656
Eur J Heart Fail. 2014 Jun;16(6):608-13
pubmed: 24644008
Circulation. 1993 May;87(5 Suppl):IV90-6
pubmed: 8097970
Eur Heart J. 2014 Jan;35(2):77-85
pubmed: 24174128
Physiol Rev. 1991 Jul;71(3):659-82
pubmed: 1647536
Catheter Cardiovasc Interv. 2017 Mar 1;89(4):E153-E161
pubmed: 27143319
Korean Circ J. 2017 Jan;47(1):9-15
pubmed: 28154583
J Am Heart Assoc. 2017 Mar 2;6(3):
pubmed: 28255080
J Card Fail. 2011 Aug;17(8):664-9
pubmed: 21807328
Heart Rhythm. 2014 Apr;11(4):541-6
pubmed: 24389229

Auteurs

Kameel Kassab (K)

Division of Cardiology, Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI 49048, USA.
Division of Cardiology, Michigan State University, Kalamazoo, MI 49048, USA.

Ronak Soni (R)

Division of Cardiology, Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI 49048, USA.
Division of Cardiology, Michigan State University, Kalamazoo, MI 49048, USA.

Adnan Kassier (A)

Division of Cardiology, Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI 49048, USA.
Division of Cardiology, Michigan State University, Kalamazoo, MI 49048, USA.

Tim A Fischell (TA)

Division of Cardiology, Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI 49048, USA.
Division of Cardiology, Michigan State University, Kalamazoo, MI 49048, USA.

Classifications MeSH